Cargando…

Impact of the Cannabinoid System in Alzheimer's Disease

Cannabinoids are compounds isolated from cannabis and are also widely present in both nervous and immune systems of animals. In recent years, with in-depth research on cannabinoids, their clinical medicinal value has been evaluated, and many exciting achievements have been continuously accumulating,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuangtao, Huang, Yuanbing, Yu, Lijun, Ji, Xiaoyu, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207907/ https://www.ncbi.nlm.nih.gov/pubmed/35105293 http://dx.doi.org/10.2174/1570159X20666220201091006

Ejemplares similares

Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint
por: Kushwah, Shikha, et al.
Publicado: (2023)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Current Naturopathy to Combat Alzheimer’s Disease
por: Chakrovorty, Arnob, et al.
Publicado: (2023)

Effects of β-caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction
por: Asth, Laila, et al.
Publicado: (2023)

The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease
por: Chachaj, Angelika, et al.
Publicado: (2023)

Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease
por: Kabir, Eva Rahman, et al.
Publicado: (2023)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues
por: He, Da-Long, et al.
Publicado: (2023)

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020)

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update
por: Khan, Sabiya Samim, et al.
Publicado: (2023)

The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: Abd-Elrahman, Khaled S., et al.
Publicado: (2023)

The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: de Lima, Izabella B.Q., et al.
Publicado: (2023)

Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer’s Disease
por: Xiong, Yu, et al.
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review
por: Xin, Yuqi, et al.
Publicado: (2022)

Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances
por: Sanfilippo, Cristina, et al.
Publicado: (2023)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease
por: Martins, Gabriela L., et al.
Publicado: (2023)

The Role of Nrf2 in Relieving Cerebral Ischemia-Reperfusion Injury
por: Sun, Yu, et al.
Publicado: (2023)

Computational Studies Applied to Linalool and Citronellal Derivatives Against Alzheimer's and Parkinson's Disorders: A Review with Experimental Approach
por: Rayff da Silva, Pablo, et al.
Publicado: (2023)

Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
por: Ruiz de Martín Esteban, Samuel, et al.
Publicado: (2022)

Neural Oscillation Disorder in the Hippocampal CA1 Region of Different Alzheimer's Disease Mice
por: Yuan, Weiming, et al.
Publicado: (2023)

mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
por: Shang, Dehao, et al.
Publicado: (2023)

Role of Circulating Exosomes in Cerebrovascular Diseases: A Comprehensive Review
por: Lu, Zhiwen, et al.
Publicado: (2023)

Development and Psychometric Validation of the 27 Item Zarit Caregiver Interview for Alzheimer’s Disease (ZCI-AD-27)
por: Bernaards, Coen A., et al.
Publicado: (2022)

Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)

TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease
por: Chen, Yuanbing, et al.
Publicado: (2022)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances
por: Bilel, Sabrine, et al.
Publicado: (2023)

Serotonergic 5-HT(7) Receptors as Modulators of the Nociceptive System
por: Bardoni, Rita
Publicado: (2023)

Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s Disease
por: Liu, Jia-Si, et al.
Publicado: (2023)

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
por: Wang, Mengya, et al.
Publicado: (2022)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Mechanism of Mesenchymal Stem Cells as a Multitarget Disease-Modifying Therapy for Parkinson's Disease
por: Unnisa, Aziz, et al.
Publicado: (2023)

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
por: Befort, Katia
Publicado: (2015)

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
por: Canepa, Elisa, et al.
Publicado: (2021)

Recent Medicinal Chemistry Studies against Neurodegenerative Diseases
por: Scotti, Luciana, et al.
Publicado: (2023)

Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases
por: Bargiotas, Panagiotis
Publicado: (2023)

The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease
por: Bhat, Shahnawaz Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odjt2lh9f6j7kalam1k37um5la